IRRAS

SE0008321202

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:59:43 03/11/2023 GMT			5-day change	1st Jan Change
0.1604 ^SEK	-1.11%		-.--%	-.--%

2023	IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index	CI
2023	IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index	CI

IRRAS AB Provides Revenue Guidance for the Year 2021

March 06, 2019 at 10:04 am

IRRAS AB announced that its board has resolved to revise the company's financial targets. The financial targets that will apply effective March 6, 2019 are: Revenue exceeding SEK 275 million in 2021.

Latest news about IRRAS AB

IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index	24/10/23	CI
IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index	24/10/23	CI
Irras Obtains Nasdaq Approval for Delisting in Stockholm	23/10/23	MT
Sweden's Irras Files for Delisting as Privatization Nears Completion	20/10/23	MT
Irras Obtains Extension for SEK20 Million Loan	16/10/23	MT
Irras Shareholder Extends, Upsizes Loan	15/09/23	MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited completed the acquisition of a 26.6% stake in IRRAS AB (OM : IRRAS).	03/09/23	CI
Swedish Medical Device Company Irras Warns of Possible High Risk of Insolvency	24/08/23	MT
IR Holding Bidco Extends Acceptance Period for Irras Takeover	22/08/23	MT
Transcript : IRRAS AB, Q2 2023 Earnings Call, Aug 04, 2023	04/08/23
Irras Extends Loan Agreement with Second-biggest Shareholder	04/08/23	MT
IRRAS AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23	CI
Irras' Independent Bid Panel Backs IR Holding's SEK143 Million Takeover Offer	24/07/23	MT
Irras Surges 19% on Takeover Offer From IR Holding Bidco	30/06/23	MT
Legacy Capital Partners S.C.A. I, Spetses Investments Ltd, Bacara Holdings Limited, Lexington Holding Assets Ltd and Panormos Holding Limited agreed to acquire IRRAS AB (OM : IRRAS) for approximately SEK 140 million.	29/06/23	CI
IRRAS AB Provides Sales Guidance for the Second Quarter of 2024	29/06/23	CI
IRRAS AB Shifts Commercial Strategy to Focus Resources on United States Market Opportunity	29/06/23	CI
IRRAS AB Announces Resignation of Eva Nilsagård as a Board Member	01/06/23	CI
Transcript : IRRAS AB, Q1 2023 Earnings Call, May 17, 2023	17/05/23
IRRAS AB Reports Earnings Results for the First Quarter Ended March 31, 2023	17/05/23	CI
IRRAS AB Auditor Raises 'Going Concern' Doubt	26/04/23	CI
Transcript : IRRAS AB, Q4 2022 Earnings Call, Feb 16, 2023	16/02/23
IRRAS AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	16/02/23	CI
IRRAS AB Announces That the Publication of the First Comparative Study	13/02/23	CI
IRRAS Receives US FDA 510(K) Clearance for Its Next Generation IRRAflow Control Unit	12/12/22	CI

Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Companyâs shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Ratings for IRRAS AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
IRRAS AB	-.--%	17.07M
STRYKER CORPORATION	+12.05%	128B
SMITH & NEPHEW PLC	-9.24%	10.88B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.29%	8.76B
GLAUKOS CORPORATION	+36.99%	5.48B
INSPIRE MEDICAL SYSTEMS, INC.	-21.98%	4.72B
AXONICS, INC.	+8.02%	3.43B
ENOVIS CORPORATION	-10.32%	2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-12.33%	2.06B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-13.53%	1.92B

Medical Devices & Implants

IRRAS AB

Equities

IRRAS

SE0008321202

Medical Equipment, Supplies & Distribution

IRRAS AB Provides Revenue Guidance for the Year 2021

Latest news about IRRAS AB

Chart IRRAS AB

Company Profile

Income Statement Evolution

Ratings for IRRAS AB

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Medical Devices & Implants